Patents Assigned to Encore Medical Asset Corporation
-
Patent number: 8167907Abstract: A therapeutic treatment table includes a plurality of table sections for supporting the body of a patient, one of which sections is a drop section. The table includes an extension/flexion section which includes a frame having a pivot axis and a terminal end, and a rotary actuator that is adapted to repeatedly pivot the frame of the extension/flexion section about the pivot axis so as to raise the terminal end of the frame during an extension phase and to lower the terminal end of the frame during a flexion phase. A mechanism is provided for setting an operational range of motion for the extension/flexion section including an operational extension limit and an operational flexion limit, so that the rotary actuator will pivot the frame of the extension/flexion section between the operational extension limit and the operational flexion limit.Type: GrantFiled: August 25, 2005Date of Patent: May 1, 2012Assignee: Encore Medical Asset CorporationInventors: Blake Pruett, Charles Brophy, Durrell Martin
-
Patent number: 8140165Abstract: Electrotherapy systems and methods for delivering an electrostimulation treatment program to a user while reducing the risk of inducing cardiac fibrillation. The systems and methods detect electrostimulation treatment program delivery characteristics, including a pulse intensity above a preset limit; a pulse duration above a preset limit; an inappropriately compensated pulse; a charge per pulse above a predetermined limit; a current improperly exiting from a stimulation channel; a current present outside of a pulse; an excitation pulse and a compensation pulse generated on different channels; an inter-pulse time less than a predetermined limit; and a time between an excitation and a compensation pulse greater than a predetermined limit. The limits are selected in relation to an objective of reducing the risk of inducing cardiac fibrillation.Type: GrantFiled: January 30, 2006Date of Patent: March 20, 2012Assignee: Encore Medical Asset CorporationInventors: Félix Bühlmann, Etienne Dunant, Steve Guex, David Truffer, Pierre-Yves Müller
-
Patent number: 8131374Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.Type: GrantFiled: August 5, 2011Date of Patent: March 6, 2012Assignee: Encore Medical Asset CorporationInventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
-
Patent number: 8024033Abstract: An electrode for an iontophoretic drug delivery system includes a retainer having a malleable characteristic. The retainer and a conductor are connected to a platform. The conductor and a dose controller are electrically coupled to the iontophoretic drug delivery system. A drug delivery matrix is operably connected to the platform and proximate the conductor wherein the conductor, the drug delivery matrix, and the dose controller cooperate to deliver a drug to a user when the electrode is affixed to the user and operably connected to the iontophoretic drug delivery system.Type: GrantFiled: February 28, 2005Date of Patent: September 20, 2011Assignee: Encore Medical Asset CorporationInventors: Ralph Koschinsky, James D. Isaacson, Robert F. Hause, Jr.
-
Patent number: 8019426Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.Type: GrantFiled: July 16, 2007Date of Patent: September 13, 2011Assignee: Encore Medical Asset CorporationInventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
-
Patent number: 7996077Abstract: An iontophoresis apparatus and method is disclosed that is suited to deliver a plurality of treatment methods such as, but not limited to, body site conductivity enhancement followed by low voltage iontophoresis.Type: GrantFiled: April 10, 2007Date of Patent: August 9, 2011Assignee: Encore Medical Asset CorporationInventors: Robert F. Hause, Jr., Jon E. Beck
-
Patent number: 7860575Abstract: Multiple channel iontophoretic devices including multiple regulators, each of which are coupled to an associated electrode. A regulated current flows through each regulator in response to a control signal. The control signal is responsive to feedback indicative of current flowing through more than one of the multiple regulators.Type: GrantFiled: May 8, 2006Date of Patent: December 28, 2010Assignee: Encore Medical Asset CorporationInventor: Robert F. Hause
-
Patent number: 7613518Abstract: A multi-mode electrical therapeutic stimulation system. The system includes circuitry for providing interferential stimulation, muscle stimulation, and pulsed DC stimulation with an automatic switchover of electrode configurations between types of interferential and muscle stimulation without the need to manually alter the positioning of the stimulation electrodes. In one embodiment, the system includes a simplified five-button user interface with pre-programmed user display screens and an operator interface through which a medical professional can alter settings, programs, and user configurations. In another embodiment, the system can also include a recharging/docking station having a built-in charging device and data port, providing for an automatic/periodic upload of compliance data from the device when the stimulator is placed in a modem cradle. A method for managing patient care associated with a patient-administered external medical device is also disclosed.Type: GrantFiled: June 15, 2005Date of Patent: November 3, 2009Assignee: Encore Medical Asset CorporationInventors: Li Qin, Gary L. Moore
-
Patent number: 7597656Abstract: A therapeutic exercise device which may be used both as a tilt table and as an exercise device includes a base and a support frame that is pivotally mounted on the base. The support frame has a lower end and an upper end. A carriage is mounted for sliding movement along at least a portion of the support frame. The carriage includes a lower section and an upper section that is pivotally attached to the lower section. The device also includes a left foot rest and a right foot rest, each of which is independently pivotally attached to the lower end of the support frame. A body-restraining belt is also provided to secure the body of a patient to the carriage.Type: GrantFiled: October 28, 2003Date of Patent: October 6, 2009Assignee: Encore Medical Asset CorporationInventor: Darin Trees
-
Patent number: 7499746Abstract: An automated adaptive muscle stimulation system and method are disclosed. The stimulation system includes at least one electrode assembly adapted to deliver a muscle stimulation signal to the tissue of a user, a sensor system adapted to detect a muscle response, and an electrical stimulation device operably coupled to the at least on electrode assembly and the sensor system, the electrical stimulation device including a control system operable to automatically diagnose at least one characteristic of a muscle from the detected muscle response and adjust at least one parameter of the muscle stimulation signal in response thereto to deliver an adjusted muscle stimulation signal. A dual mode muscle stimulation system adapted to accept first and second data sets and provide first and second levels of treatment data is also disclosed.Type: GrantFiled: January 28, 2005Date of Patent: March 3, 2009Assignee: Encore Medical Asset CorporationInventors: Felix Buhlmann, Pierre-Yves Lampo, Pierre Rigaux, Pierre-Yves Muller, David Truffer, Klaus Schönenberger
-
Patent number: 7381214Abstract: A therapeutic treatment table includes a frame and a table section for supporting at least a portion of the body of a patient. The table section includes a body support and a drop mechanism that is mounted between the frame and the body support and adapted to drop the body support from an upper position to a lower position. A fluid actuator is mounted between the frame and the body support and adapted to raise the body support from the lower position to the upper position, and a mechanism is provided for controlling the flow of fluid to the fluid actuator in order to control the rate by which the fluid actuator raises the body support from the lower position to the upper position.Type: GrantFiled: August 24, 2005Date of Patent: June 3, 2008Assignee: Encore Medical Asset CorporationInventor: Blake Pruett
-
Publication number: 20080058698Abstract: An electrode for an iontophoretic drug delivery system includes a retainer having a malleable characteristic. The retainer and a conductor are connected to a platform. The conductor and a dose controller are electrically coupled to the iontophoretic drug delivery system. A drug delivery matrix is operably connected to the platform and proximate the conductor wherein the conductor, the drug delivery matrix, and the dose controller cooperate to deliver a drug to a user when the electrode is affixed to the user and operably connected to the iontophoretic drug delivery system.Type: ApplicationFiled: February 28, 2005Publication date: March 6, 2008Applicants: IOMED, INC., ENCORE MEDICAL ASSET CORPORATION, BANK OF AMERICA, N.A., AS COLLATERAL AGENTInventors: Ralph Koschinsky, James D. Isaacson, Robert F. Hause
-
Patent number: 7323013Abstract: A prosthetic femoral implant for use in a hip joint, as a ball and socket type joint, is disclosed. The implant includes a modular neck having a variety of adjustable positions to adjust the lateral offset and version angle of the femoral implant in relation to the femur. The implant further includes a broad, full collar for providing a compression force increasing the interdigitation between the interface of the bone, implant and cement. The implant also includes a stem having a depression having a roughened porous surface for resisting the increased torsional loads placed on the implant due to the increased lateral offset and version angle. The stem further comprises three distinct zones, each zone having its own roughened surface creating a tripartite differential porosity.Type: GrantFiled: September 13, 2002Date of Patent: January 29, 2008Assignee: Encore Medical Asset CorporationInventors: Timothy McTighe, Ian Murray, Hugh U. Cameron
-
Patent number: 7254444Abstract: The electrical nerve stimulation unit in accordance with the present invention generally includes a housing, an input panel, a display panel, a controller, a first channel output, a second channel output, and a power system. While the device is generally described in terms of use as a TENS unit, it must be noted that other nerve stimulation applications for the device are envisioned as well. The myriad of intelligent and proactive programmable software functions and features of the present invention are executed on the controller's microprocessor. For instance, open lead monitoring, soft recovery implementation, compliance monitoring, and enhanced power management are all controlled and monitored through the interfacing of the processor with the various devices and hardware on the unit's hardware platform.Type: GrantFiled: October 17, 2002Date of Patent: August 7, 2007Assignee: Encore Medical Asset CorporationInventors: Gary L. Moore, John Czech, Bisrat Woldegiorges, Michael Karas
-
Patent number: D505726Type: GrantFiled: August 16, 2004Date of Patent: May 31, 2005Assignee: Encore Medical Asset CorporationInventor: Bradley Peter Ryan
-
Patent number: D506260Type: GrantFiled: October 27, 2003Date of Patent: June 14, 2005Assignee: Encore Medical Asset CorporationInventor: Bradley Peter Ryan
-
Patent number: D508998Type: GrantFiled: August 16, 2004Date of Patent: August 30, 2005Assignee: Encore Medical Asset CorporationInventor: Bradley Peter Ryan
-
Patent number: D511008Type: GrantFiled: October 27, 2003Date of Patent: October 25, 2005Assignee: Encore Medical Asset CorporationInventor: Bradley Peter Ryan
-
Patent number: D513615Type: GrantFiled: October 27, 2003Date of Patent: January 17, 2006Assignee: Encore Medical Asset CorporationInventor: Bradley Peter Ryan
-
Patent number: D636493Type: GrantFiled: November 12, 2008Date of Patent: April 19, 2011Assignee: Encore Medical Asset CorporationInventor: Rainer Teufel